Related Experiment Video
Updated: Jun 19, 2025

07:44
Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
7.5K
Progress in reeducating tumor-associated macrophages in tumor microenvironment
Yiming Zhao1, Qianyang Ni1, Weijian Zhang1
1Department of Gastrointestinal Surgery, The Third Hospital of Hebei Medical University, No.139, Ziqiang Road, Qiaoxi District, Shijiazhuang, 050051, China.
Discover Oncology
|July 26, 2024
Summary
Reprogramming tumor-associated macrophages (TAM) is key to improving cancer immunotherapy. This review categorizes methods to alter the tumor microenvironment (TME) and enhance anti-tumor immunity.
Area of Science:
- Oncology
- Immunology
- Biomedical Engineering
Background:
- Malignant tumors remain a significant global health threat, with conventional therapies offering suboptimal prognoses.
- Immunotherapy has emerged as a promising cancer treatment, but its full potential is hindered by challenges within the tumor microenvironment (TME).
- Macrophages, particularly tumor-associated macrophages (TAMs), are crucial innate immune cells within the TME, influencing immune responses and tumor progression.
Purpose of the Study:
- To explore strategies for reprogramming the TME to enhance anti-tumor immunity.
- To investigate methods for altering the recruitment and polarization of TAMs.
- To provide a comprehensive overview of current approaches for modulating TAMs for improved cancer therapy.
Main Methods:
- Review and categorization of existing therapeutic approaches targeting TAMs.
- Analysis of methods including nanoparticles and photodynamic therapy for their impact on macrophage polarization.
- Organization of strategies for reprogramming TAMs within the TME.
Main Results:
- Identified various therapeutic modalities capable of influencing macrophage polarization within the TME.
- Highlighted the critical role of TAM reprogramming in overcoming immunotherapy obstacles.
- Provided a structured overview of current TAM-targeting strategies.
Conclusions:
- Reprogramming TAMs is a promising strategy to enhance the efficacy of cancer immunotherapy.
- Understanding and manipulating the TME, particularly TAM behavior, is essential for developing novel tumor therapies.
- This review offers insights into clinical applications of TAM-reprogramming strategies for future cancer treatments.

